Congenital retinal arteriovenous communication is a rare, birth‑present blood vessel abnormality in the retina. People with congenital retinal arteriovenous communication may notice blurred vision, blind spots, or headaches, and doctors may see enlarged, tangled vessels on eye exam. The condition is lifelong, but vision changes can be stable or slowly progressive. Many living with congenital retinal arteriovenous communication do well with monitoring, and treatment is aimed at complications like swelling or bleeding. If you notice early symptoms of congenital retinal arteriovenous communication such as new floaters or sudden vision changes, prompt eye care can help protect sight.
Overview
Congenital retinal arteriovenous communicationSymptoms
Early signs of congenital retinal arteriovenous communication are often absent and it’s found during an eye exam. When noticeable, features include blurred or reduced vision, distortion, or visual field gaps—usually in one eye. Floaters can occur with bleeding.
Outlook and prognosis
Most people with congenital retinal arteriovenous communication remain stable for years and keep useful vision, especially when one eye is affected. Problems can arise from bleeding or swollen retina, which are often manageable. Regular eye exams help catch and treat changes early.
Causes and risk factors
Congenital retinal arteriovenous communication usually arises from a blood-vessel development change before birth, most often sporadic. Rarely, it occurs with wider vascular syndromes or familial predisposition. No proven lifestyle or environmental risk factors are known.
Genetic influences
Genetics play a limited role in congenital retinal arteriovenous communication; most cases appear sporadic. Rare familial patterns exist, sometimes linked with wider vascular conditions. Genetic testing is usually unnecessary unless there are multiple lesions or systemic vascular findings.
Diagnosis
Diagnosis of congenital retinal arteriovenous communication starts with a dilated eye exam showing direct artery-to-vein links. Confirmation relies on retinal imaging (fluorescein angiography, OCT). MRI of the brain and orbits may be added to look for associated malformations.
Treatment and drugs
Treatment for congenital retinal arteriovenous communication focuses on protecting vision, easing symptoms, and watching for complications. Eye doctors often monitor closely with imaging; laser, anti‑VEGF injections, or surgery may be used if bleeding, swelling, or glaucoma develops. Managing blood pressure and prompt care for new floaters, vision blur, or pain are important.
Symptoms
Congenital retinal arteriovenous communication involves abnormal, direct links between retinal arteries and veins that are present from birth. Some people notice no eye changes for years, while others develop vision problems if the area for sharp sight is involved. Early features of congenital retinal arteriovenous communication may include blurred or distorted vision in one eye or new floaters after a small bleed. Features can vary from person to person and may change over time.
Many people with congenital retinal arteriovenous communication notice no vision problems at first. The finding often shows up during a routine eye exam.
The condition is usually in one eye, while the other eye sees normally. Depth perception can feel slightly off if vision differs between the eyes.
If the sharp-vision center (macula) is involved, reading or seeing fine detail can blur. Faces may look less crisp in the affected eye.
Straight lines may look bent or rippled. This can reflect swelling or stress on the center of vision.
How people usually first notice Congenital retinal arteriovenous communication?
Many families first notice something is off when a child doesn’t track faces or toys well, bumps into objects, or seems unusually sensitive to light; sometimes a pediatrician spots a white or unusual reflex in the pupil during an exam. In congenital retinal arteriovenous communication, doctors often pick it up at the first dilated eye check after parents report vision concerns, or incidentally during a routine screening when they see abnormal, tangled retinal vessels. For many, the first signs of congenital retinal arteriovenous communication are changes in visual behavior in infancy or early childhood and an atypical red reflex, prompting referral to a pediatric ophthalmologist for detailed imaging.
Types of Congenital retinal arteriovenous communication
Congenital retinal arteriovenous communication is a rare, present-from-birth blood vessel difference in the retina that can look and behave in a few distinct ways. These variants mainly describe how arteries and veins connect and how much of the retina is involved, which in turn shapes risk for vision changes over time. People may notice different sets of symptoms depending on their situation. When discussing types of congenital retinal arteriovenous communication, eye specialists usually rely on well-recognized clinical subtypes seen on exam and imaging.
Type 1 (limited)
Abnormal artery-to-vein connections are small and localized, often without a direct artery-to-vein shunt. Vision is usually normal or only mildly affected, and many are found incidentally during routine eye exams. Monitoring is common, with low risk of complications.
Type 2 (direct shunt)
A larger, direct connection exists between an artery and a vein without a capillary bed in between. This can cause the vein to look enlarged and pulsatile and may raise the risk of retinal bleeding or swelling. Some may notice blurred or distorted vision in the affected eye.
Type 3 (extensive)
Widespread, tangled artery–vein connections involve much of the retina and can extend toward the optic nerve. This type carries the highest risk of vision loss from bleeding, fluid buildup, or traction on the retina. Early symptoms of congenital retinal arteriovenous communication here may include sudden blur, floaters, or a shadow in the visual field.
What genetics can tell you about symptoms
Some people with congenital retinal arteriovenous communication develop blurry vision, floaters, or vision loss when the abnormal artery–vein connections leak or bleed, and doctors may see vessel tangles or retinal swelling. Larger or more numerous malformations raise the risk of hemorrhage and macular damage.
Causes and risk factors
Congenital retinal arteriovenous communication forms before birth when retinal blood vessels develop abnormally and an artery connects directly to a vein. Most cases are sporadic and not inherited, so family history usually does not raise your risk. Doctors distinguish between risk factors you can change and those you can’t, and there are no proven lifestyle or environmental risks for this condition. Rarely, it occurs with syndromes that also involve brain or facial blood vessels, such as Wyburn-Mason syndrome. Early symptoms of congenital retinal arteriovenous communication may be absent, so it is often found during a routine eye exam rather than through warning signs.
Environmental and biological risk factors
If you or your child are being evaluated for congenital retinal arteriovenous communication, it’s natural to wonder what might raise the chance before birth. Doctors often group risks into internal (biological) and external (environmental). People sometimes worry about early symptoms of congenital retinal arteriovenous communication, but the likelihood is set during fetal development rather than by later exposures. Below are the key biological features and what we know about environmental links.
During fetal development, unusual direct links can form between retinal arteries and veins. This early vascular patterning difference is the core biological driver when congenital retinal arteriovenous communication is present. Most cases arise without a traceable trigger beyond this developmental variation.
When arteriovenous malformations occur in nearby brain or facial regions, the chance of congenital retinal arteriovenous communication may be higher as part of the same developmental pattern. This reflects a broader biological tendency for blood vessels in those areas to develop abnormally during the same window of growth. In these cases, the eye findings often coexist with vascular changes elsewhere rather than occurring in isolation.
Specific environmental exposures during pregnancy have not been shown to increase risk for congenital retinal arteriovenous communication. Research to date has not found consistent links with radiation, heavy metals, air pollution, or common chemicals.
Most diagnoses are sporadic, with no identifiable external trigger. This suggests the underlying risk comes from early vascular development rather than environmental exposures.
Genetic risk factors
Congenital retinal arteriovenous communication usually starts from developmental changes in the eye blood vessels present from birth, and most cases are isolated rather than inherited. Carrying a genetic change doesn’t guarantee the condition will appear. A smaller group have this finding as part of wider vascular syndromes caused by single-gene changes that can run in families. Understanding the genetic causes of congenital retinal arteriovenous communication can guide when to consider family evaluation or genetic testing.
Sporadic mosaic changes: In many, congenital retinal arteriovenous communication forms from a random, early change in a blood-vessel gene during development. This mosaic change is not inherited and usually does not raise the chance for future children.
Wyburn-Mason syndrome: Some people have retinal arteriovenous connections along with brain or facial arteriovenous malformations in a pattern called Wyburn-Mason syndrome. It appears to arise from an early, noninherited change, so family members are typically not at increased risk. Genetic testing usually does not find a passed-down cause in this syndrome.
CM-AVM syndromes: Changes in the RASA1 or EPHB4 genes can cause capillary malformation-arteriovenous malformation syndromes, which sometimes include the eye or retina. These conditions are autosomal dominant, so each child of an affected parent has a 50% (1 in 2) chance to inherit the gene change. In these families, congenital retinal arteriovenous communication may be one of several vascular findings.
HHT gene changes: Changes in ENG, ACVRL1, or SMAD4 cause hereditary hemorrhagic telangiectasia, a condition with arteriovenous malformations in several organs. Retinal arteriovenous malformations are uncommon in HHT but have been reported. A family history of frequent nosebleeds or organ AVMs can be a clue to consider testing.
Family history pattern: When similar vascular findings appear in several close relatives, an inherited syndrome becomes more likely. If congenital retinal arteriovenous communication occurs alone with no other features, a familial cause is less likely. A genetics consult can help sort out which patterns suggest testing.
Lifestyle risk factors
This condition is present at birth, and lifestyle habits do not cause it. However, daily choices can influence eye blood flow, pressure, and the risk of bleeding or vision changes. Focusing on vascular health and trauma prevention may help reduce complications and preserve function. The points below highlight lifestyle risk factors for Congenital retinal arteriovenous communication and practical ways to lower them.
High blood pressure can strain fragile retinal vessels and raise the risk of hemorrhage. Reducing sodium, managing stress, and regular moderate activity can help keep blood pressure steady.
Heavy lifting or breath-holding (Valsalva) can spike venous pressure in the eye. Choosing controlled breathing and avoiding maximal straining may reduce bleeding risk.
Blunt eye trauma can trigger retinal hemorrhage or sudden vision loss in this condition. Using sport-specific eye protection or choosing non-contact alternatives lowers injury risk.
Nicotine and smoke damage blood vessels and increase clotting and spasm, which can worsen retinal circulation through the AV connection. Quitting reduces bleeding and ischemia risks.
Risk prevention
For congenital retinal arteriovenous communication, you can’t prevent the condition itself, but you can lower the chance of vision problems and other complications. Prevention is about lowering risk, not eliminating it completely. The focus is on regular monitoring, protecting the eye from injury, and staying on top of changes quickly. Work with your care team to personalize follow-up and safety steps for your age, lifestyle, and any related brain or eye findings.
See a retina specialist on a set schedule to monitor for bleeding, fluid, or pressure changes from congenital retinal arteriovenous communication. Imaging like OCT or angiography may be used to track subtle changes over time.
Ask about baseline brain and orbit imaging if your doctor suspects related vascular changes (sometimes seen with this condition). Finding issues early can guide safe activity choices and follow-up plans.
Keep blood pressure in a healthy range to reduce the likelihood of eye bleeding or sudden vessel stress. Work with your clinician on targets and home monitoring if needed.
Use shatter-resistant safety glasses for sports, yardwork, and DIY projects. Preventing blunt eye trauma may lower the risk of bleeding or sudden vision changes.
Transmission
Congenital retinal arteriovenous communication is not infectious; it cannot be caught or spread between people in any way. It is a present-from-birth connection between a retinal artery and vein, and in most people it happens sporadically, without a family history.
Because there is usually no genetic transmission of congenital retinal arteriovenous communication, relatives generally are not at increased risk. In uncommon situations where similar vessel changes occur alongside other features, your clinician may discuss how congenital retinal arteriovenous communication is inherited and whether a genetics review is appropriate.
When to test your genes
Test your genes if you have congenital retinal arteriovenous communication plus vision changes, early-onset retinal issues in relatives, or features suggesting a known syndrome (like Wyburn-Mason). Consider testing before pregnancy or eye surgery to guide monitoring and family planning. Seek genetics referral if diagnosis is unclear or there’s multisystem involvement.
Diagnosis
Congenital retinal arteriovenous communication is usually identified during an eye exam when unusual blood vessel patterns are seen. Many people feel relief just knowing what’s really going on. From there, your eye doctor uses imaging and vision tests to confirm the findings and check how much the vessels are affecting sight. This stepwise approach explains how the diagnosis of congenital retinal arteriovenous communication is made and whether any related issues need attention.
Doctors usually begin by examining the back of the eye with the pupils widened. They look for unusually large, twisted vessels that connect an artery directly to a vein. These patterns are often present from birth and are usually in one eye.
A small amount of dye is injected into a vein in your arm, and photos track how it flows through the retinal vessels. Veins may fill rapidly from arteries without the usual capillary phase, which supports the diagnosis. This test can also show areas of leakage or stress on nearby retina.
Optical coherence tomography (OCT) takes cross‑section images to check for swelling or changes in the macula. OCT angiography (OCTA) maps blood flow without dye and can show the direct artery‑to‑vein connections. Together, they provide a detailed baseline for follow‑up.
Standard eye‑chart testing measures how clearly you see at distance and near. Refraction checks whether glasses can improve blur that sometimes accompanies retinal changes. Tracking these results over time helps monitor impact on daily vision.
Stages of Congenital retinal arteriovenous communication
Congenital retinal arteriovenous communication does not have defined progression stages. It’s a blood vessel connection present from birth that often stays fairly stable, though vision can change if swelling or bleeding happens. Different tests may be suggested to help confirm the diagnosis, such as a dilated eye exam, retina imaging, and a safe dye test to see blood flow; some people are also checked for similar vessels in the brain if symptoms point that way. If vision changes arise, eye specialists usually monitor with regular check-ups and imaging; knowing the early symptoms of congenital retinal arteriovenous communication—like new floaters, sudden blur, or a dark patch in your sight—can prompt timely care.
Outlook and prognosis
Living with congenital retinal arteriovenous communication can mean vision changes that vary widely from person to person. Some people never notice issues beyond routine eye checks, while others develop symptoms like blurred spots, brief dimming, or floaters during reading or in bright light. Everyone’s journey looks a little different. The main risks come from complications such as retinal bleeding, swelling near the center of vision, or, rarely, a type of stroke inside the eye that can cause sudden vision loss.
Looking at the long-term picture can be helpful. Many people maintain stable sight for years, especially when the malformation is small and away from the macula—the area needed for sharp vision. Early symptoms of congenital retinal arteriovenous communication, like new floaters or a shadow in one part of your view, should prompt a same‑week eye exam because timely laser, injections, or observation can limit damage. Most cases do not affect life expectancy, but vision-related quality of life can be impacted if bleeding or scarring recurs.
When the vessel tangle is extensive or sits at the center of the retina, the chance of vision loss is higher, and multiple treatments over time may be needed. Very rarely, these eye findings occur alongside similar vessel changes in the brain; imaging may be recommended if your eye specialist is concerned, as this can influence overall risk. In medical terms, the long-term outlook is often shaped by both genetics and lifestyle. Talk with your doctor about what your personal outlook might look like.
Long-term effects
Congenital retinal arteriovenous communication can be stable for years, but some people see changes in vision over time, especially if the macula is involved. Long-term effects vary widely, and the outlook depends on where the vessel tangles sit and how much the central retina or optic nerve is affected. Some live with mild blur in one eye, while others develop complications like swelling or bleeding that reduce clarity. Doctors often follow the condition over time to watch for new leakage, pressure changes, or signs beyond the eye.
Many live with lower sharpness in the affected eye, especially if the macula is involved. This may remain steady or gradually change with episodes of swelling or bleeding.
Straight lines can look wavy, and small blind spots may appear in the visual field. These features reflect how the vessel tangle disrupts the retina’s usual signal pathways.
Unequal vision from early life can lead to a “lazy eye” pattern. Parents may first notice drifting or squinting as early signs of congenital retinal arteriovenous communication.
Fragile vessels can leak or bleed within the retina. Repeated episodes may leave scars that reduce clarity.
How is it to live with Congenital retinal arteriovenous communication?
Living with congenital retinal arteriovenous communication often means regular eye checkups and watching for changes in vision, because the abnormal connection between a retinal artery and vein can leak, bleed, or cause swelling that blurs sight in one eye. Many people have no symptoms for years, while others notice floaters, distorted lines, or a sudden drop in vision during a bleed, which can make reading, driving at night, or screen work harder. Family, teachers, or coworkers may need to understand that vision can fluctuate and that bright light, high-contrast print, extra time, or spacing on tasks can help on tougher days. Most find that with monitoring by an eye specialist and timely treatment if complications arise, daily life remains manageable and independence stays intact.
Treatment and drugs
Treatment for congenital retinal arteriovenous communication focuses on protecting vision, since many people never develop symptoms and don’t need procedures right away. Regular eye exams with retinal imaging help track blood vessel changes and catch problems like swelling, bleeding, or high eye pressure early. If leakage or macular swelling affects sight, doctors may use targeted laser, eye injections that reduce leakage, or occasionally surgery to manage complications such as retinal detachment or non‑clearing hemorrhage. Managing blood pressure and avoiding eye trauma can lower the risk of bleeding, and your doctor may coordinate care if there are vessel changes outside the eye. Not every treatment works the same way for every person, so plans are individualized and adjusted over time based on vision, imaging, and symptoms.
Non-drug treatment
Non-drug care focuses on protecting vision, watching for changes, and treating complications promptly. Non-drug treatments often lay the foundation for day-to-day safety and vision stability. Plans are individualized, since congenital retinal arteriovenous communication can look very different from one eye to another. Your eye team will guide timing for observation versus procedures based on risks and early changes.
Scheduled eye exams with imaging help track vessel changes and catch bleeding or swelling early. This is key because early symptoms of congenital retinal arteriovenous communication can be subtle. Report any new floaters, blurred spots, or sudden vision dimming right away.
Protective glasses or sports eyewear can lower the chance of eye injury that might trigger bleeding. This is especially helpful for contact sports, home repairs, or jobs with flying debris. Keep safety eyewear readily available.
Low-vision services can optimize remaining sight with magnifiers, contrast tools, and lighting adjustments. Training can make reading, driving assessment, and daily tasks easier. These supports can reduce fatigue and improve confidence.
For children with one weaker eye, patching or blurring the stronger eye can strengthen vision in the affected eye. Early, consistent therapy often leads to better long-term sight. Your pediatric eye team will set the schedule.
Your genes may have an impact on how drugs work for you
Genes can affect how your body processes eye medications, changing how well they work or how likely side effects are. Pharmacogenetic testing isn’t routine for congenital retinal arteriovenous communication, but doctors consider family history, ancestry, and prior drug responses when tailoring treatment.
Pharmacological treatments
Medicines for congenital retinal arteriovenous communication focus on treating complications like swelling at the macula, bleeding, or high eye pressure rather than the vessel tangle itself. Early symptoms of congenital retinal arteriovenous communication may be minimal, so treatment often starts only when vision changes or exam findings appear. Some medicines are given as eye injections, while others are eye drops or short courses of tablets. Not everyone responds to the same medication in the same way.
Bevacizumab, ranibizumab, or aflibercept can calm leaky vessels and reduce macular swelling. They are injected into the eye at intervals and may improve or stabilize vision.
Timolol, brimonidine, dorzolamide, or latanoprost can reduce high eye pressure if neovascular or secondary glaucoma develops. These are used daily and adjusted based on pressure readings.
Acetazolamide tablets can quickly lower eye pressure or help short-term with stubborn macular fluid. Side effects can include tingling in fingers, frequent urination, or fatigue.
Triamcinolone injections or a dexamethasone implant can lessen retinal inflammation and fluid when anti-VEGF alone is not enough. Short courses of steroid eye drops like prednisolone may be used around procedures.
Genetic influences
For most people, congenital retinal arteriovenous communication develops as a one-time change early in eye development and is not inherited. In rare situations, similar eye vessel changes appear as part of a broader inherited vascular condition that can also cause capillary birthmarks or arteriovenous malformations in the skin, brain, or other organs. Family history is one of the strongest clues to a genetic influence. If you or relatives have multiple vascular findings, your eye specialist may suggest genetic counseling and, in select situations, genetic testing for congenital retinal arteriovenous communication to look for a wider pattern. Even when a genetic cause is present, how noticeable the eye changes are—and whether other body areas are involved—can vary widely, even within the same family. Understanding whether your case is inherited or a sporadic finding can guide monitoring for you and, when appropriate, close relatives.
Is Congenital retinal arteriovenous communication genetic?
Genetics play a limited role in congenital retinal arteriovenous communication; most cases appear sporadic. Rare familial patterns exist, sometimes linked with wider vascular conditions. Genetic testing is usually unnecessary unless there are multiple lesions or systemic vascular findings.
Pharmacogenetics—how genetics influence drug effects
Treatment for complications of Congenital retinal arteriovenous communication often relies on eye injections, pressure‑lowering drops, or careful monitoring, rather than long‑term tablets. When medicines are used, your individual biology may play a small but meaningful role in how well they work and whether side effects show up. Genes can influence how quickly you process certain pressure‑lowering eye drops, such as beta‑blockers like timolol, which can change how strong the effect feels and the chance of slow heart rate or fatigue. If Congenital retinal arteriovenous communication leads to macular swelling managed with steroid eye injections or drops, some people are “steroid responders” who get a bigger rise in eye pressure, so your eye team may monitor more closely and adjust treatment. Response to anti‑VEGF injections can vary from person to person, but there isn’t a clinically proven genetic test yet to predict medication response in Congenital retinal arteriovenous communication. In rare cases where related brain vessel malformations are treated and anti‑platelet medicines are used, gene differences can guide drug choice or dose, and your specialists will tailor this if needed.
Interactions with other conditions
People living with congenital retinal arteriovenous communication sometimes also have similar blood vessel tangles in the brain or orbit (around the eye), a pattern known as Wyburn‑Mason syndrome. These intracranial arteriovenous malformations can bring their own issues—headaches, seizures, or a stroke risk—which may compound vision symptoms if eye pressure rises or bleeding occurs. Talk with your doctor about how your conditions may influence each other. High blood pressure, clotting problems, or the need for blood thinners because of another illness can make retinal bleeding more likely, while diabetes can add swelling in the macula that further blurs sight. Congenital retinal arteriovenous communication can also overlap with other facial or skin vascular anomalies, and eye specialists often coordinate with neurology and neurosurgery to plan safe monitoring. Some people first learn about it during a workup for neurological symptoms rather than from early symptoms of congenital retinal arteriovenous communication in the eye, so shared care helps ensure nothing is missed.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Families and communities once noticed patterns—newborns who seemed to see normally at first, then later struggled to track faces or bumping into objects in dim light. Some parents recalled one eye looking different on exam photos, or a doctor remarking on unusual blood vessels during a school screening. These everyday clues often came long before a name was attached to what we now call congenital retinal arteriovenous communication.
First described in the medical literature as a striking tangle of retinal vessels present from birth, early reports focused on what clinicians could see with the ophthalmoscope: arteries and veins connecting directly without the usual tiny capillaries between them. Initially understood only through symptoms, later case series linked these eye findings with risks like bleeding inside the eye or, rarely, reduced vision in childhood. Over time, descriptions became more precise as better lenses, photography, and fluorescein angiography allowed doctors to map the vessel pathways and understand how blood flow bypassing capillaries could stress the retina.
From early theories to modern research, the story of congenital retinal arteriovenous communication has been one of sharpening definitions. Some early accounts grouped many vessel anomalies together. As medical science evolved, clinicians learned to separate this condition from look‑alikes such as retinal macroaneurysms or general vascular malformations, because the course and complications can differ. Not every early description was complete, yet together they built the foundation of today’s knowledge.
In recent decades, awareness has grown that these vessel connections are present at birth and may stay stable for years, while a subset can lead to problems such as leakage, swelling, or hemorrhage. Wider use of eye imaging in infants and children, plus routine eye photographs, made it easier to spot changes over time and to decide when careful observation is enough versus when treatment is needed. Reports also noted that many people with congenital retinal arteriovenous communication have no symptoms and are found incidentally, while others may notice early symptoms like blurred spots, reduced side vision, or sudden floaters if bleeding occurs.
Advances in genetics shifted the conversation further. While most cases appear isolated to the eye, research into vascular development helped explain how, during early growth, a small area of the retina can form a direct “shortcut” between an artery and a vein. This understanding supported safer monitoring plans and, when appropriate, targeted treatments to lower the risk of bleeding or fluid buildup.
Today’s approach reflects this history: careful diagnosis to confirm the specific vessel pattern, regular follow‑up to watch for change, and tailored care based on symptoms and risk. Knowing the condition’s history helps explain why your clinician may recommend long‑term monitoring even when vision is good—because experience shows that stable periods are common, and timely action matters if problems arise.